HomeNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Previous close
$0.47
Day range
$0.46 - $0.48
Year range
$0.40 - $1.09
Market cap
547.39M USD
Avg Volume
1.59M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
.INX
1.26%
1.00%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 445.00K | -25.46% |
Operating expense | 8.13M | -13.69% |
Net income | -18.92M | 33.14% |
Net profit margin | -4.25K | 10.31% |
Earnings per share | — | — |
EBITDA | -14.72M | 17.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.13M | -69.48% |
Total assets | 27.86M | -11.04% |
Total liabilities | 74.92M | -45.06% |
Total equity | -47.06M | — |
Shares outstanding | 1.19B | — |
Price to book | -7.77 | — |
Return on assets | -127.55% | — |
Return on capital | 5,020.56% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -18.92M | 33.14% |
Cash from operations | -16.96M | -91.64% |
Cash from investing | -418.00K | 80.65% |
Cash from financing | 14.42M | 26.99% |
Net change in cash | -3.97M | -61.42% |
Free cash flow | -10.48M | -244.57% |